Chinese billionaire Tianqiao Chen as recently as February used his 10% stake in Legg Mason to gain two board seats at the asset-management firm, including the vice chairmanship for himself. His designs for CHS haven't been made public but he already carries weight with his holdings.
A rule that would set new ceiling prices in the 340B drug discount program has been delayed until mid-2018 while HHS considers alternative regulations.
Modern Healthcare is proud to present the 150 companies and organizations that have been named to its Best Places to Work in Healthcare for 2017. An alphabetical list of the companies and organizations is presented here.
A leading U.S. hospital pulled its annual fundraiser from Donald Trump's Mar-a-Lago resort on Thursday, reversing course after initially resisting pressure from health professionals and others over the president's support for repealing the Affordable Care Act and cutting federal research dollars.
Although insurers asked for a 17.7% increase, New York's Department of Financial Services approved a 14.6% bump as it factored in the potential loss of cost sharing–reduction payments that insurers use to cover out-of-pocket expenses for lower-income consumers.
Mylan allegedly misclassified EpiPens as a generic drug, which may have cost the government up to $1.27 billion in lost Medicaid rebates, according to federal estimates.
Bayada Home Health Care described the move to not-for-profit as the first of its kind in the industry, driven by a motivation to sustain the organization for multiple generations and bolster recruiting and retention efforts.
As policymakers and the drug and device industry look for new ways to bring treatments for life-threatening conditions to the market sooner, providers are concerned that expedited approvals could compromise patient care.
Patients walking in the front door of the University of Minnesota Health Clinics and Surgery Center in Minneapolis may do a double take, thinking instead that they've entered an Apple store.
The long-term care industry has taken steps to create more patient-centered care plans that are resulting in less use of antipsychotics, but some doctors are worried the trend may lead to some patients not getting the drugs they need.
Longtime UnitedHealth CEO Stephen Hemsley will step down Sept. 1, and President David Wichmann will take over. The change marks a major leadership shakeup at the nation's largest health plan.
Share your opinion in the latest edition of our bi-weekly reader poll. Do you think Congress will pass a healthcare reform bill after the August recess?